Gnubiotics Sciences SA is thrilled to announce that Prof. Church, a distinguished geneticist & synthetic biologist, has joined the Gnubiotics SAB.
With a remarkable career, he pioneered the 1st direct genomic sequencing method and lead groundbreaking human & subsequent personal genome projects. As a Professor at Harvard Medical School & MIT Massachusetts Institute of Technology, and founding member of the Wyss Institute at Harvard University, Prof. Church brings invaluable expertise to the Gnubiotics team of senior scientific advisors.
His dedication to pushing boundaries of innovation is evident through co-founding around 50 biotech companies and making his own lab a hub of biotech startup activity. Prof. Church’s commitment to advancing science aligns seamlessly with Gnubiotics’ mission in glycopeptide-mediated immunotherapy such as breaking the tumour glycocode.
